The Oracle Pedigree and Serialization Manager (OPSM) is now available from Oracle (Redwood Shores, CA), some 10 months after the company announced its intention to develop the product. The company says that OPSM is an “integrated mass-serialization and pedigree application” that “generates, stores, transmits and authenticates drug product serial data and ePedigree data.” Integrated analytics allow for improving efficiencies in distribution processes, returns, chargeback reconciliation and related transactional use cases.
“This is a standalone, out-of-the-box solution,” says Arvindh Balakrishnan, VP, Oracle life sciences business unit. “It has built-in business-intelligence capabilities to automate threat analysis, or to manage returns processes and reconciliation.”
Company product literature describes the OPSM as making use of the service-oriented architecture of Oracle Fusion Middleware, which acts as a connectivity solution for moving data from OPSM to ERP systems or other enterprise IT systems, and compatible with Web services, which provide means for transmitting data over the Web.
Andy Binsley, a senior director in Oracle’s manufacturing and asset life-cycle management product strategy group, notes that the company worked with a focus group of manufacturers, including one of the Big Three wholesalers, in designing the product, and that “we are monitoring standards-development processes in the GS1 organization closely” to ensure compatibility as those standards evolve.
Oracle’s offering enters a item-level serialization space not well defined by IT competitors. Companies like Systech (Cranbury, NJ) provide IT solutions to generate and transmit serial numbers; SAP and IBM have applications that store serial data; Axway (Phoenix, AZ) and rfXcel (San Ramon, CA) have solutions that both collect serial data and generate drug-pedigree documents. The GS1 organization continues to work on standards for these applications, while the pharma industry pays closer attention to the 2015 deadline for e-pedigree implementation in the State of California.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.